
|Articles|March 11, 2022
Choose Eurofins’ new state-of-the-art aseptic sterile fill/finish for clinical supplies
Author(s)Eurofins BioPharma Product Testing
Industry changes, such as shorter timelines and increased product complexity, can often introduce additional risks to the sterile fill/finish process, resulting in production delays, additional costs, and safety concerns.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
2
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
3
Behind the Headlines Episode 32: AI’s Power, NVIDIA & Lilly, Revolution Medicine
4
Women Leading Biotech: Advancing Treatments for Ovarian Cancer
5